Genetic Testing Services Global Market Report 2025
상품코드:1704449
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 200 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
유전자 검사 서비스 시장 규모는 향후 수년간 급성장이 전망됩니다. 2029년에는 CAGR 11.2%로 327억 7,000만 달러로 성장합니다. 예측 기간 중의 성장은 비침습적 산전검사(NIPT)에 대한 수요 증가, 약물유전체학의 부상, 예방적 헬스케어에 대한 관심 증가, DTC(Direct-to-Consumer) 검사 증가, 희귀질환 및 맞춤치료에 대한 관심 증가 등에 기인하는 것으로 분석됩니다. 예측 기간의 주요 동향으로는 인공지능(AI)과 머신러닝, 사용자 친화적인 검사 키트 및 온라인 플랫폼의 발전, 차세대 시퀀싱, 마이크로어레이 분석, 중합효소연쇄반응(PCR), 첨단 헬스케어 인프라 등이 있습니다.
유전성 질환의 유병률 증가는 향후 유전자 검사 서비스 시장의 성장을 가속할 것으로 예상됩니다. 유전성 질환은 개인의 DNA 이상에 기인하여 다양한 신체적 또는 발달적 이상을 초래합니다. 유전 질환의 유병률 증가 요인으로는 인식 개선, 진단 방법의 개선, 유전자 검사 구상의 확대, 특정 집단의 근친혼 발생률 증가 등을 들 수 있습니다. 유전자 검사 서비스는 유전성 질환의 진단, 예후 예측, 치료 전략 결정에 매우 중요한 역할을 하고 있으며, 유전정보에 기반한 맞춤형 의료 및 가족계획 결정을 촉진하고 있습니다. 예를 들어 세계보건기구(WHO)가 2023년 2월에 보고한 바와 같이, 선천성 질환은 매년 전 세계에서 출생 후 28일 이내에 약 24만 명의 영아를 사망에 이르게 하는 원인입니다. 또한 미국 질병예방통제센터(CDC)에 따르면 미국에서는 연간 약 6,000명의 다운증후군 아동이 태어나고 있으며, 이는 약 700명당 1명의 비율입니다. 따라서 유전성 질환의 유병률 증가는 유전자 검사 서비스 시장 성장의 원동력이 되고 있습니다.
유전자 검사 서비스 시장의 주요 업체들은 정확도를 높이고, 검사 역량을 확대하며, 전반적인 환자 결과를 개선하기 위해 암 선별 검사와 같은 기술 솔루션의 발전에 주력하고 있습니다. 암 선별 검사는 암의 조기 징후를 발견하기 위해 무증상자에게 시행하는 정기적인 검사입니다. 이러한 검사는 증상이 나타나기 전에 암이나 전암 상태를 식별하여 보다 효과적인 치료 개입을 가능하게 하는 것을 목표로 합니다. 예를 들어 Prenetics Group Limited는 2022년 6월 홍콩에서 고감도 스크리닝 방법을 활용하여 대장암의 조기 징후를 감지하는 비침습적 대변 DNA 검사 콜로클리어(ColoClear)를 발표했습니다. 첨단 대변 DNA 기술과 대변 면역화학검사(FIT)를 결합한 ColoClear는 대장내시경 검사를 대체할 수 있는 편리하고 효율적인 검사방법을 제공합니다. 임상 연구를 통해 ColoClear의 대장암 검출 민감도는 96%, 진행성 선종 검출 민감도는 64%인 것으로 입증되었습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스 및 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 유전자 검사 서비스 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 유전자 검사 서비스 시장 : 성장률 분석
세계의 유전자 검사 서비스 시장 실적 : 규모와 성장, 2019-2024
세계의 유전자 검사 서비스 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 유전자 검사 서비스 TAM(Total Addressable Market)
제6장 시장 세분화
세계의 유전자 검사 서비스 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
예측 테스트
캐리어 테스트
출생전 검사
신생아 스크리닝
기타 유형
세계의 유전자 검사 서비스 시장 : 질환별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
암질환
대사성 질환
심혈관질환
기타 질병
세계의 유전자 검사 서비스 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
진단 검사실
병원과 진료소
학술기관 및 연구 센터
기타 최종사용자
세계의 유전자 검사 서비스 시장 예측 테스트의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
암소인 검사
심장병 리스크 검사
신경질환 리스크 검사
기타 예측 테스트
세계의 유전자 검사 서비스 시장 캐리어 테스트의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
단일 유전자 질환 보인자 스크리닝
다요인 질환 캐리어 스크리닝
유전성 질환 보인자 스크리닝
기타 캐리어 검사
세계의 유전자 검사 서비스 시장 출생전 검사의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
비침습적 출생전 검사(NIPT)
양수천자
융모막융모 채취(CVS)
초음파와 조합한 유전자 검사
기타 출생전 검사
세계의 유전자 검사 서비스 시장 신생아 스크리닝의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
대사장애 스크리닝
유전성 질환 스크리닝
난청 스크리닝
내분비 질환 스크리닝
기타 신생아 스크리닝 검사
세계의 유전자 검사 서비스 시장, 기타 유형의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
약리유전학적 검사
법의학적 유전자 검사
조상과 유전자 계보 검사
친자 감정
기타 전문적인 유전자 검사
제7장 지역별·국가별 분석
세계의 유전자 검사 서비스 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 유전자 검사 서비스 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
유전자 검사 서비스 시장 : 경쟁 구도
유전자 검사 서비스 시장 : 기업 개요
F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
Laboratory Corporation of America Holdings(LabCorp) Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Quest Diagnostics Incorporated
Eurofins Scientific SE
SGS SA
Agilent Technologies
Hologic Inc.
Illumina Inc.
PerkinElmer Inc.
bioMerieux SA
Bio-Rad Laboratories Inc.
QIAGEN N.V.
Natera Inc.
Myriad Genetics Inc.
BGI Genomics Co. Ltd.
Invitae Corporation
NeoGenomics Laboratories Inc
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
유전자 검사 서비스 시장 2029 : 새로운 기회를 제공하는 국가
유전자 검사 서비스 시장 2029 : 새로운 기회를 제공하는 부문
유전자 검사 서비스 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁의 전략
제36장 부록
KSA
영문 목차
영문목차
Genetic testing services involve the analysis of an individual's DNA to detect variations or mutations that may indicate disease susceptibility, ancestry information, or other genetic characteristics. These services typically provide insights into potential health risks, ancestral origins, and personalized recommendations based on genetic predispositions, aiding in informed medical decisions and lifestyle choices.
The primary categories of genetic testing services include predictive testing, carrier testing, prenatal testing, newborn screening, and other specialized tests. Predictive testing assesses an individual's risk of developing specific conditions such as cancer, metabolic disorders, cardiovascular diseases, and others. These services are utilized by a variety of stakeholders including diagnostic laboratories, hospitals and clinics, academic institutions, research centers, and others.
The genetic testing services market research report is one of a series of new reports from The Business Research Company that provides genetic testing services market statistics, including genetic testing services industry global market size, regional shares, competitors with a genetic testing services market share, detailed genetic testing services market segments, market trends and opportunities, and any further data you may need to thrive in the genetic testing services industry. This genetic testing services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The genetic testing services market size has grown rapidly in recent years. It will grow from $19.19 billion in 2024 to $21.42 billion in 2025 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to increasing demand for personalized and precision medicine, growing prevalence of genetic disorders, high demand for prenatal testing during pregnancy, increasing population, and increased awareness and education.
The genetic testing services market size is expected to see rapid growth in the next few years. It will grow to $32.77 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to the growing demand for non-invasive prenatal testing (NIPT), the rise of pharmacogenomics, the growing focus on preventive healthcare, increasing direct-to-consumer (DTC) testing, and the focus on rare diseases and personalized therapies. Major trends in the forecast period include artificial intelligence (AI) and machine learning, advancements in user-friendly testing kits and online platforms, next-generation sequencing, microarray analysis, polymerase chain reaction (PCR), and advanced healthcare infrastructure.
The rising prevalence of genetic disorders is anticipated to drive the growth of the genetic testing services market in the future. Genetic disorders, stemming from abnormalities in an individual's DNA, result in various physical or developmental abnormalities. Factors contributing to the increased prevalence of genetic disorders include heightened awareness, improved diagnostic methods, expanded genetic screening initiatives, and a growing incidence of consanguineous marriages in certain populations. Genetic testing services play a pivotal role in diagnosing, prognosing, and determining treatment strategies for individuals with genetic disorders, facilitating personalized medical care and family planning decisions based on genetic information. For example, as reported by the World Health Organization (WHO) in February 2023, congenital diseases are responsible for approximately 240,000 infant deaths globally within the first 28 days of birth each year. Additionally, according to the Centers for Disease Control and Prevention (CDC), approximately 6,000 babies are born with Down syndrome in the United States annually, translating to about 1 in every 700 births. Hence, the escalating prevalence of genetic disorders is a driving force behind the growth of the genetic testing services market.
Key players in the genetic testing services market are concentrating on advancing technological solutions, such as cancer screening tests, to enhance precision, broaden testing capabilities, and improve patient outcomes overall. Cancer screening tests are routine examinations conducted on asymptomatic individuals to detect early signs of cancer. These tests aim to identify cancer or precancerous conditions before symptoms manifest, enabling more effective treatment interventions. For instance, in June 2022, Prenetics Group Limited introduced ColoClear, a non-invasive stool DNA test in Hong Kong, leveraging highly sensitive screening methods to detect early indications of colorectal cancer. Combining advanced stool DNA technology with fecal immunochemical testing (FIT), ColoClear offers a convenient and efficient alternative to colonoscopy. Clinical studies have demonstrated ColoClear's sensitivity of 96% in colorectal cancer detection and 64% in advanced adenoma detection.
In November 2022, Myriad Genetics Inc. bolstered its presence in women's health and oncology testing by acquiring Gateway Genomics for $67.5 million. This strategic move expands Myriad's portfolio of comprehensive and personalized genetic testing solutions for patients. Gateway Genomics LLC, a US-based genetics company specializing in genetic testing services, complements Myriad's capabilities in the field.
Major companies operating in the genetic testing services market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, SGS SA, Agilent Technologies, Hologic Inc., Illumina Inc., PerkinElmer Inc., bioMerieux SA, Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, NeoGenomics Laboratories Inc, 23andMe Holding Co, Berry Genomics Co. Ltd, Pacific Biosciences of California Inc, Ambry Genetics Corporation, Biocartis SA, CENTOGENE N.V., Blueprint Genetics Oy, Igenomix, Veritas Genetics
North America was the largest region in the genetic testing services market in 2024. The regions covered in the genetic testing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the genetic testing services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The genetic testing services market consists of revenues earned by entities by providing services such as newborn screening, diagnostic testing, carrier testing, prenatal testing, preimplantation testing, predictive and presymptomatic testing, ancestry testing, nutrigenomics testing, and forensic testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Genetic Testing Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on genetic testing services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for genetic testing services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genetic testing services market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Predictive Testing; Carrier Testing; Prenatal Testing; Newborn Screening; Other Types
2) By Disease: Cancer Disease; Metabolic Disease; Cardiovascular Disease; Other Diseases
3) By End User: Diagnostic Laboratories; Hospitals And Clinics; Academic Institutes And Research Centers; Other End Users
Subsegments:
1) By Predictive Testing: Cancer Predisposition Testing; Heart Disease Risk Testing; Neurological Disorder Risk Testing; Other Predictive Tests
2) By Carrier Testing: Carrier Screening For Single-Gene Disorders; Carrier Screening For Multifactorial Conditions; Carrier Screening For Inherited Genetic Conditions; Other Carrier Tests
3) By Prenatal Testing: Non-Invasive Prenatal Testing (NIPT); Amniocentesis; Chorionic Villus Sampling (CVS); Ultrasound-Combined Genetic Testing; Other Prenatal Tests
4) By Newborn Screening: Metabolic Disorder Screening; Genetic Disorder Screening; Hearing Loss Screening; Endocrine Disorder Screening; Other Newborn Screening Tests
5) By Other Types: Pharmacogenetic Testing; Forensic Genetic Testing; Ancestry And Genetic Genealogy Testing; Paternity Testing; Other Specialized Genetic Tests
Companies Mentioned: F. Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Laboratory Corporation of America Holdings (LabCorp)
3. Genetic Testing Services Market Trends And Strategies
4. Genetic Testing Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Genetic Testing Services Growth Analysis And Strategic Analysis Framework
5.1. Global Genetic Testing Services PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Genetic Testing Services Market Growth Rate Analysis
5.4. Global Genetic Testing Services Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Genetic Testing Services Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Genetic Testing Services Total Addressable Market (TAM)
6. Genetic Testing Services Market Segmentation
6.1. Global Genetic Testing Services Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Predictive Testing
Carrier Testing
Prenatal Testing
Newborn Screening
Other Types
6.2. Global Genetic Testing Services Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cancer Disease
Metabolic Disease
Cardiovascular Disease
Other Diseases
6.3. Global Genetic Testing Services Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostic Laboratories
Hospitals And Clinics
Academic Institutes And Research Centers
Other End Users
6.4. Global Genetic Testing Services Market, Sub-Segmentation Of Predictive Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cancer Predisposition Testing
Heart Disease Risk Testing
Neurological Disorder Risk Testing
Other Predictive Tests
6.5. Global Genetic Testing Services Market, Sub-Segmentation Of Carrier Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Carrier Screening For Single-Gene Disorders
Carrier Screening For Multifactorial Conditions
Carrier Screening For Inherited Genetic Conditions
Other Carrier Tests
6.6. Global Genetic Testing Services Market, Sub-Segmentation Of Prenatal Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Non-Invasive Prenatal Testing (NIPT)
Amniocentesis
Chorionic Villus Sampling (CVS)
Ultrasound-Combined Genetic Testing
Other Prenatal Tests
6.7. Global Genetic Testing Services Market, Sub-Segmentation Of Newborn Screening, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Metabolic Disorder Screening
Genetic Disorder Screening
Hearing Loss Screening
Endocrine Disorder Screening
Other Newborn Screening Tests
6.8. Global Genetic Testing Services Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmacogenetic Testing
Forensic Genetic Testing
Ancestry And Genetic Genealogy Testing
Paternity Testing
Other Specialized Genetic Tests
7. Genetic Testing Services Market Regional And Country Analysis
7.1. Global Genetic Testing Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Genetic Testing Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
